Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia by Bradley Rockwell, Mendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, Yogen Saunthararajah, Kira Gritsman, Alejandro R. Sica, Noah Kornblum, Nishi Shah, David Levitz, Lauren C. Shapiro, Ridhi Gupta, Anne Munoz, Aradhika Dhawan, Karen Fehn, Monica Comas, Jhannine Verceles, Dennis L. Cooper, Marina Konopleva, Eric J. Feldman, Amit Verma

Get full text